~~<i id='9955029AC0'><strike id='9955029AC0'><tt id='9955029AC0'><pre id='9955029AC0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：entertainment 2025-09-29 03:47:07 - browse：383

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Cloning humans is technically possible. It's curious no one has tried

knowledge

explore

hotspot

knowledge

focus

Wikipedia

KobiWolf/BloombergPfizersaidTuesdaythatamuch-watchedstudyofitsantiviralPaxlovidinpatientswhohaveCovi

WSS

Inflation cooled significantly in June, bringing price hikes close to normal levels

Blinken talks high

Watch the official trailer for 'Ahsoka' series

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Disclosing genetic information: not as worrisome as once feared

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

focus

focus

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Guidelines to prevent youth baseball injuries need more muscle

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Peter Hotez and the public health issue of online harassment

Companies helping big Covid

The high cost of giving birth even with insurance

STAT's guide to the next generation of CAR

As demand for Covid shots wanes, Moderna seeks its next success

Watch the official trailer for 'Ahsoka' series

explore

Companies helping big Covid

Grail's uphill battle for Medicare to cover its cancer screening test

The story of mRNA: From a loose idea to a tool that may help curb Covid

The battle over the Brookhaven Landfill on Long Island

After half a century, Israel moves to evict squatter from his cave home on the beach

What would happen to your eyes if you looked at the solar eclipse?

hotspot

knowledge

focus

Wikipedia